AAPL294.09+4.73 (+1.63%) ▲|ABBV250.46-1.18 (-0.47%) ▼|ABT91.99+1.25 (+1.38%) ▲|ACN133.69+9.25 (+7.43%) ▲|ADBE211.66+6.64 (+3.24%) ▲|AMAT642.79-80.22 (-11.09%) ▼|AMD550.87-30.04 (-5.17%) ▼|AMGN358.85-3.27 (-0.90%) ▼|AMT167.08+3.51 (+2.15%) ▲|AMZN244.01+5.67 (+2.38%) ▲|AVGO369.88-7.88 (-2.08%) ▼|AXP348.36+10.11 (+2.99%) ▲|BA217.42+0.95 (+0.44%) ▲|BAC58.31+1.33 (+2.33%) ▲|BKNG184.07+5.83 (+3.27%) ▲|BLK979.29+17.73 (+1.84%) ▲|BMY56.35-1.28 (-2.21%) ▼|BNY146.80+2.19 (+1.51%) ▲|BRK-B502.27+1.88 (+0.38%) ▲|C139.73-0.24 (-0.17%) ▼|CAT995.45-69.45 (-6.52%) ▼|CL92.18+0.50 (+0.55%) ▲|CMCSA24.09-0.47 (-1.89%) ▼|COF203.87+3.25 (+1.62%) ▲|COP103.55-0.41 (-0.39%) ▼|COST925.88-9.60 (-1.03%) ▼|CRM164.60+7.94 (+5.07%) ▲|CSCO116.40-1.06 (-0.90%) ▼|CVS104.62+1.17 (+1.13%) ▲|CVX166.22+0.46 (+0.28%) ▲|DE628.68-5.65 (-0.89%) ▼|DHR193.65+3.17 (+1.66%) ▲|DIS96.53+0.28 (+0.29%) ▲|DUK125.55-1.04 (-0.82%) ▼|EMR140.56-2.60 (-1.81%) ▼|FDX315.06+1.93 (+0.62%) ▲|GD362.21+7.97 (+2.25%) ▲|GE371.57-2.16 (-0.58%) ▼|GEV1,138.85-36.01 (-3.07%) ▼|GILD126.08-0.26 (-0.21%) ▼|GM75.52-1.57 (-2.03%) ▼|GOOG356.07+2.74 (+0.77%) ▲|GOOGL359.17+1.80 (+0.50%) ▲|GS1,024.54+13.17 (+1.30%) ▲|HD353.46+0.78 (+0.22%) ▲|HON220.93-2.97 (-1.33%) ▼|IBM289.18+7.97 (+2.83%) ▲|INTC128.11-11.53 (-8.25%) ▼|INTU270.19+9.19 (+3.52%) ▲|ISRG401.91+4.23 (+1.06%) ▲|JNJ252.47-1.51 (-0.59%) ▼|JPM333.67+6.34 (+1.94%) ▲|KO81.40+0.13 (+0.15%) ▲|LIN536.36+17.42 (+3.36%) ▲|LLY1,175.64-23.79 (-1.98%) ▼|LMT517.91+8.45 (+1.66%) ▲|LOW223.14+2.65 (+1.20%) ▲|LRCX386.96-46.37 (-10.70%) ▼|MA526.21+12.61 (+2.46%) ▲|MCD271.02+0.71 (+0.26%) ▲|MDLZ58.73+0.89 (+1.53%) ▲|MDT78.92+0.69 (+0.88%) ▲|META622.54+59.25 (+10.52%) ▲|MMM160.87-1.04 (-0.64%) ▼|MO72.17+0.22 (+0.30%) ▲|MRK126.10-2.41 (-1.87%) ▼|MS211.85+2.81 (+1.34%) ▲|MSFT387.67+14.65 (+3.93%) ▲|MU1,044.93-109.37 (-9.47%) ▼|NEE86.73-1.04 (-1.18%) ▼|NFLX74.01+2.61 (+3.66%) ▲|NKE42.02+0.97 (+2.35%) ▲|NOW106.39+7.11 (+7.16%) ▲|NVDA198.75-1.35 (-0.67%) ▼|ORCL143.87-2.69 (-1.83%) ▼|PEP140.59+5.19 (+3.83%) ▲|PFE23.80-0.29 (-1.18%) ▼|PG146.10-0.54 (-0.37%) ▼|PLTR127.54+10.87 (+9.32%) ▲|PM179.59-1.32 (-0.73%) ▼|QCOM183.81-0.98 (-0.53%) ▼|RTX190.13+0.40 (+0.21%) ▲|SBUX103.42+1.23 (+1.20%) ▲|SCHW95.82+3.55 (+3.84%) ▲|SO95.23-0.48 (-0.50%) ▼|SPG221.12-2.53 (-1.13%) ▼|T20.64-0.06 (-0.28%) ▼|TMO514.97+13.61 (+2.71%) ▲|TMUS173.29+5.56 (+3.31%) ▲|TSLA426.19+5.59 (+1.33%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.24+1.08 (+1.50%) ▲|UNH425.67+10.04 (+2.42%) ▲|UNP278.20+6.20 (+2.28%) ▲|UPS110.08+2.58 (+2.40%) ▲|USB62.07+1.67 (+2.76%) ▲|V351.73+8.64 (+2.52%) ▲|VZ42.02-0.33 (-0.77%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.33-4.93 (-4.35%) ▼|XOM136.32-0.40 (-0.29%) ▼|AAPL294.09+4.73 (+1.63%) ▲|ABBV250.46-1.18 (-0.47%) ▼|ABT91.99+1.25 (+1.38%) ▲|ACN133.69+9.25 (+7.43%) ▲|ADBE211.66+6.64 (+3.24%) ▲|AMAT642.79-80.22 (-11.09%) ▼|AMD550.87-30.04 (-5.17%) ▼|AMGN358.85-3.27 (-0.90%) ▼|AMT167.08+3.51 (+2.15%) ▲|AMZN244.01+5.67 (+2.38%) ▲|AVGO369.88-7.88 (-2.08%) ▼|AXP348.36+10.11 (+2.99%) ▲|BA217.42+0.95 (+0.44%) ▲|BAC58.31+1.33 (+2.33%) ▲|BKNG184.07+5.83 (+3.27%) ▲|BLK979.29+17.73 (+1.84%) ▲|BMY56.35-1.28 (-2.21%) ▼|BNY146.80+2.19 (+1.51%) ▲|BRK-B502.27+1.88 (+0.38%) ▲|C139.73-0.24 (-0.17%) ▼|CAT995.45-69.45 (-6.52%) ▼|CL92.18+0.50 (+0.55%) ▲|CMCSA24.09-0.47 (-1.89%) ▼|COF203.87+3.25 (+1.62%) ▲|COP103.55-0.41 (-0.39%) ▼|COST925.88-9.60 (-1.03%) ▼|CRM164.60+7.94 (+5.07%) ▲|CSCO116.40-1.06 (-0.90%) ▼|CVS104.62+1.17 (+1.13%) ▲|CVX166.22+0.46 (+0.28%) ▲|DE628.68-5.65 (-0.89%) ▼|DHR193.65+3.17 (+1.66%) ▲|DIS96.53+0.28 (+0.29%) ▲|DUK125.55-1.04 (-0.82%) ▼|EMR140.56-2.60 (-1.81%) ▼|FDX315.06+1.93 (+0.62%) ▲|GD362.21+7.97 (+2.25%) ▲|GE371.57-2.16 (-0.58%) ▼|GEV1,138.85-36.01 (-3.07%) ▼|GILD126.08-0.26 (-0.21%) ▼|GM75.52-1.57 (-2.03%) ▼|GOOG356.07+2.74 (+0.77%) ▲|GOOGL359.17+1.80 (+0.50%) ▲|GS1,024.54+13.17 (+1.30%) ▲|HD353.46+0.78 (+0.22%) ▲|HON220.93-2.97 (-1.33%) ▼|IBM289.18+7.97 (+2.83%) ▲|INTC128.11-11.53 (-8.25%) ▼|INTU270.19+9.19 (+3.52%) ▲|ISRG401.91+4.23 (+1.06%) ▲|JNJ252.47-1.51 (-0.59%) ▼|JPM333.67+6.34 (+1.94%) ▲|KO81.40+0.13 (+0.15%) ▲|LIN536.36+17.42 (+3.36%) ▲|LLY1,175.64-23.79 (-1.98%) ▼|LMT517.91+8.45 (+1.66%) ▲|LOW223.14+2.65 (+1.20%) ▲|LRCX386.96-46.37 (-10.70%) ▼|MA526.21+12.61 (+2.46%) ▲|MCD271.02+0.71 (+0.26%) ▲|MDLZ58.73+0.89 (+1.53%) ▲|MDT78.92+0.69 (+0.88%) ▲|META622.54+59.25 (+10.52%) ▲|MMM160.87-1.04 (-0.64%) ▼|MO72.17+0.22 (+0.30%) ▲|MRK126.10-2.41 (-1.87%) ▼|MS211.85+2.81 (+1.34%) ▲|MSFT387.67+14.65 (+3.93%) ▲|MU1,044.93-109.37 (-9.47%) ▼|NEE86.73-1.04 (-1.18%) ▼|NFLX74.01+2.61 (+3.66%) ▲|NKE42.02+0.97 (+2.35%) ▲|NOW106.39+7.11 (+7.16%) ▲|NVDA198.75-1.35 (-0.67%) ▼|ORCL143.87-2.69 (-1.83%) ▼|PEP140.59+5.19 (+3.83%) ▲|PFE23.80-0.29 (-1.18%) ▼|PG146.10-0.54 (-0.37%) ▼|PLTR127.54+10.87 (+9.32%) ▲|PM179.59-1.32 (-0.73%) ▼|QCOM183.81-0.98 (-0.53%) ▼|RTX190.13+0.40 (+0.21%) ▲|SBUX103.42+1.23 (+1.20%) ▲|SCHW95.82+3.55 (+3.84%) ▲|SO95.23-0.48 (-0.50%) ▼|SPG221.12-2.53 (-1.13%) ▼|T20.64-0.06 (-0.28%) ▼|TMO514.97+13.61 (+2.71%) ▲|TMUS173.29+5.56 (+3.31%) ▲|TSLA426.19+5.59 (+1.33%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.24+1.08 (+1.50%) ▲|UNH425.67+10.04 (+2.42%) ▲|UNP278.20+6.20 (+2.28%) ▲|UPS110.08+2.58 (+2.40%) ▲|USB62.07+1.67 (+2.76%) ▲|V351.73+8.64 (+2.52%) ▲|VZ42.02-0.33 (-0.77%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.33-4.93 (-4.35%) ▼|XOM136.32-0.40 (-0.29%) ▼|
33.9 C
New York
Wednesday, July 1, 2026

Tag: programs

newssourceFORcompanyinformationcontent1releasesmarket

CF & CFRP Market worth $35.55 billion in 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 4, 2025 /PRNewswire/ -- The report "CF & CFRP Market by Precursor Type (PAN, Pitch), Source, Resin Type, Manufacturing Process (Lay-Up,...

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Shanghai summer kicks off with ‘Easy Go’

SHANGHAI, July 4, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn ...

WIC briefs media on Digital Silk Road Development Forum

BEIJING, July 4, 2025 /PRNewswire/ -- A news report from CRI Online:   The World Internet Conference (WIC) held a press conference in Beijing on July 3...

Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai

SHANGHAI, July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative...

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with Centessa. The milestones were achieved as Centessa initiated clinical development of ORX142, its second novel orexin receptor 2 (OX2R) agonist, following the recent clearance of an Investigational New Drug (IND) application by the US Food and Drug Administration (FDA) for a Phase 1 clinical study of ORX142 in healthy volunteers. (click here).

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE

Snow Caps THCA Flower – Extra Frosty Exotic Cannabis Strains Now Available for Sale

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

NeuroEnergizer 2025 Update Positions OTC Audio Program at Forefront of Cognitive Wellness Movement

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025. 
Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

March of Dimes Statement on the Passage of H.R. 1

ARLINGTON, Va., July 3, 2025 /PRNewswire-HISPANIC PR WIRE/ -- The passage of H.R. 1, the "One Big Beautiful Bill Act," sets in motion harmful...

March of Dimes Statement on the Passage of H.R. 1

ARLINGTON, Va., July 3, 2025 /PRNewswire/ -- The passage of H.R. 1, the "One Big Beautiful Bill Act," sets in motion harmful changes to...

Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+ 
New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrograms

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers